Custom Health Holdings Inc. (TSX:CHLT)
| Market Cap | 71.36M |
| Revenue (ttm) | 44.01M +79.5% |
| Net Income | -93.12M |
| EPS | -3.56 |
| Shares Out | 25.95M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,137 |
| Open | 3.760 |
| Previous Close | 3.850 |
| Day's Range | 2.750 - 3.850 |
| 52-Week Range | 2.750 - 11.000 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 20, 2026 |
About Custom Health Holdings
Custom Health Holdings Inc., an AI-enabled healthcare technology company that operates an infrastructure platform designed to ensure medication therapy works as intended. The company connects in-home technology, pharmacy, and pharmacist-led clinicians to create continuous visibility into a patient's therapy. Its AdhereNet platform operates an integrated pharmacy network across Canada and the U.S. supporting medication delivery, continuous monitoring, and clinical action to enable earlier engagement and support improved outcomes. The company ser... [Read more]
Financial Performance
In 2025, Custom Health Holdings's revenue was $18.32 million, a decrease of -1.57% compared to the previous year's $18.61 million. Losses were -$29.79 million, 20.2% more than in 2024.
Financial numbers in USD Financial StatementsNews
Custom Health Holdings Report: Q3 2026
Custom Health Holdings published a report on November 16, 2026 containing material business information for investors and shareholders.
Custom Health Holdings MD&A: Q3 2026
Custom Health Holdings filed a regulatory document on November 16, 2026 disclosing important business information.
Custom Health Holdings Earnings release: Q3 2026
Custom Health Holdings released its Q3 2026 earnings on November 16, 2026, summarizing the period's financial results.
Custom Health Holdings Slides: Investor presentation
Custom Health Holdings has posted slides in relation to its latest quarterly earnings report, which was published on September 16, 2026.
Custom Health Holdings Report: Q2 2026
Custom Health Holdings published a report on August 14, 2026 containing material business information for investors and shareholders.
Custom Health Holdings MD&A: Q2 2026
Custom Health Holdings filed a regulatory document on August 14, 2026 disclosing important business information.
Custom Health Holdings Earnings release: Q2 2026
Custom Health Holdings released its Q2 2026 earnings on August 14, 2026, summarizing the period's financial results.
Custom Health Holdings initiated with a Buy at Stifel
Stifel initiated coverage of Custom Health Holdings (CHLT.TO) with a Buy rating and C$12 price target Custom Health’s end-to-end platform addresses medication non-adherence, notes the analyst, who exp...
Custom Health Holdings Report: Q4 2025
Custom Health Holdings published a report on July 2, 2026 containing material business information for investors and shareholders.
Custom Health Holdings Annual report: Q4 2025
Custom Health Holdings has published its Q4 2025 annual report on July 2, 2026.
Custom Health Holdings Earnings release: Q1 2026
Custom Health Holdings released its Q1 2026 earnings on July 2, 2026, summarizing the period's financial results.
Custom Health Holdings Report: Q1 2026
Custom Health Holdings published a report on July 2, 2026 containing material business information for investors and shareholders.